Basic information Safety Supplier Related

EFAROXAN HYDROCHLORIDE

Basic information Safety Supplier Related

EFAROXAN HYDROCHLORIDE Basic information

Product Name:
EFAROXAN HYDROCHLORIDE
Synonyms:
  • EFAROXAN HYDROCHLORIDE
  • 2-ETHYL-2-(IMIDAZOLIN-2-YL)-2,3-DIHYDROBENZOFURAN HYDROCHLORIDE
  • (+/-)-2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-4,5-DIHYDRO-1H-IMIDAZOLE HYDROCHLORIDE
  • 2-(2-Ethyl-2,3-dihydrobenzofuran-2-yl)-4,5-dihydro-1H-imidazole hydrochloride
  • EfaroxanHCl
  • RX 821037A, 2-Ethyl-2-(imidazolin-2-yl)-2,3-dihydrobenzofuran hydrochloride
  • Zinc00002748
  • RX 821037A
CAS:
89197-00-2
MF:
C13H17ClN2O
MW:
252.74
Product Categories:
  • Adrenoceptor
Mol File:
89197-00-2.mol
More
Less

EFAROXAN HYDROCHLORIDE Chemical Properties

storage temp. 
Store at RT
solubility 
H2O: 300 mg/mL
form 
solid
color 
White
Water Solubility 
Soluble to 100 mM in water
Stability:
Stable for 1 year from date of purchase as supplied. Solutions in distilled water may be stored at -20° for up to 1 month.
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
25
Safety Statements 
7-35-45
RIDADR 
UN 2811 6.1/PG 3
WGK Germany 
3

MSDS

More
Less

EFAROXAN HYDROCHLORIDE Usage And Synthesis

Description

Efaroxan HCl (89197-00-2) is a selective α2-adrenergic receptor antagonist1 (selectivity ratio of α2/α1 = 724)4 and imidazoline receptor antagonist2. Induces release of insulin in the rat insulinoma cell line RIN-5AH by interaction with ATP-sensitive potassium channels independently from imidazoline I1 or I2 receptors.3 Efaroxan HCl increases resting plasma insulin levels and markedly potentiates the rise in insulin levels produced by adrenaline in the rat.4

Uses

Efaroxan Hydrochloride is a potent α2-AR adrenoceptor antagonist.

Biological Activity

Potent, highly selective α 2 adrenoceptor antagonist and imidazoline I 1 receptor ligand (pK i values are 7.87, 7.42, 5.74, 7.28 and < 5 for α 2A , α 2B , α 2C , I 1 , and I 2 receptors respectively). Promotes insulin secretion, at a site distinct from I 1 or I 2 (the putative I 3 receptor) in vitro and in vivo .

References

1) Chapleo et al. (1984), alpha-Adrenoceptor reagents. 2. Effects of modification of the 1,4-benzodioxan ring system on alpha-adrenoceptor activity; J.Med.Chem., 27 570 2) Eglen et al. (1998), ‘Seeing through a glass darkly’: casting light on imidazoline ‘I’ sites; Trends Pharmacol. Sci., 19 381 3) Olmos et al. (1994), Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors; Eur. .J. Pharmacol., 262 41 4) Berridge et al. (1992), Comparison of the effects of efaroxan and glibenclamide on plasma glucose and insulin levels in rats; Eur. J. Pharmacol., 213 205

EFAROXAN HYDROCHLORIDESupplier

ChemeGen(Shanghai) Biotechnology Co.,Ltd. Gold
Tel
18818260767
Email
sales@chemegen.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Shanghai T&W Pharmaceutical Co., Ltd.
Tel
+86 21 61551611
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-6206333 18521732826;
Email
market@aladdin-e.com
EMMX Biotechnology LLC
Tel
888-539-0666
Email
info@emmx.com